DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $6,848,420 | -1.1% | 27,410 | -1.1% | 0.31% | -5.2% |
Q1 2024 | $6,923,501 | -2.4% | 27,725 | -9.6% | 0.33% | -4.1% |
Q4 2023 | $7,096,071 | -6.6% | 30,674 | +0.2% | 0.34% | -18.4% |
Q3 2023 | $7,597,239 | +3.2% | 30,622 | -0.2% | 0.42% | +14.5% |
Q2 2023 | $7,360,467 | -4.0% | 30,669 | +0.8% | 0.37% | -11.2% |
Q1 2023 | $7,670,973 | -6.1% | 30,436 | -1.1% | 0.41% | -10.6% |
Q4 2022 | $8,170,550 | +1.7% | 30,783 | -1.0% | 0.46% | -8.9% |
Q3 2022 | $8,035,000 | -0.6% | 31,107 | -2.4% | 0.51% | +10.0% |
Q2 2022 | $8,083,000 | -13.6% | 31,884 | -0.0% | 0.46% | -11.2% |
Q1 2022 | $9,354,000 | -10.2% | 31,888 | +0.7% | 0.52% | -11.3% |
Q4 2021 | $10,416,000 | +6.6% | 31,659 | -1.3% | 0.58% | -1.5% |
Q3 2021 | $9,769,000 | +9.2% | 32,089 | -3.7% | 0.59% | +8.6% |
Q2 2021 | $8,945,000 | +18.5% | 33,330 | -0.6% | 0.55% | +11.2% |
Q1 2021 | $7,546,000 | -9.4% | 33,527 | -10.5% | 0.49% | -11.7% |
Q4 2020 | $8,326,000 | +1.2% | 37,479 | -1.9% | 0.56% | -11.0% |
Q3 2020 | $8,230,000 | +18.8% | 38,219 | -2.4% | 0.62% | +13.0% |
Q2 2020 | $6,926,000 | +21.4% | 39,168 | -5.0% | 0.55% | +2.0% |
Q1 2020 | $5,706,000 | -9.7% | 41,226 | +0.1% | 0.54% | -5.4% |
Q4 2019 | $6,321,000 | +16.6% | 41,186 | +9.7% | 0.57% | +12.6% |
Q3 2019 | $5,423,000 | -2.8% | 37,548 | -3.8% | 0.51% | -11.0% |
Q2 2019 | $5,580,000 | +3.9% | 39,045 | -4.0% | 0.57% | +4.4% |
Q1 2019 | $5,370,000 | +24.9% | 40,675 | -2.5% | 0.55% | +18.4% |
Q4 2018 | $4,300,000 | -5.5% | 41,703 | -0.4% | 0.46% | +6.7% |
Q3 2018 | $4,550,000 | +9.8% | 41,877 | -0.3% | 0.43% | +6.1% |
Q2 2018 | $4,143,000 | +702.9% | 41,984 | +696.8% | 0.41% | -17.9% |
Q1 2018 | $516,000 | -86.2% | 5,269 | -87.0% | 0.50% | +33.5% |
Q4 2017 | $3,749,000 | +10.9% | 40,385 | +2.5% | 0.37% | +3.3% |
Q3 2017 | $3,381,000 | – | 39,418 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |